Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bone Biologics (BBLG) Invested Capital (2016 - 2017)

Bone Biologics (BBLG) has disclosed Invested Capital for 2 consecutive years, with $2.7 million as the latest value for Q3 2017.

  • On a quarterly basis, Invested Capital rose 33.42% to $2.7 million in Q3 2017 year-over-year; TTM through Sep 2017 was $2.7 million, a 33.42% increase, with the full-year FY2016 number at -$7.2 million, changed N/A from a year prior.
  • Invested Capital was $2.7 million for Q3 2017 at Bone Biologics, up from $2.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $5.8 million in Q1 2016 to a low of -$7.2 million in Q4 2016.